OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
38
Results
Show all
Save search
Copy query
Show results for
Genomics
(24)
Unknown
(14)
Organisms
Homo sapiens
(24)
Repository
EGA
(24)
Technology Type
Illumina 15K
(8)
Illumina 1.2M, Affymetrix 6.0, Affymetrix 6.0 - CHIAMO
(1)
Publication Date
Release Date
2021
(5)
2022
(3)
2023
(2)
2026
(1)
2025
(1)
2020
(1)
2018
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
The research data management platform (RDMP): A novel, process driven, open-source tool for the management of longitudinal cohorts of clinical data.
Not available
S-EPMC6041881
|
biostudies-literature
Cite
PR
Pharmacogenomic response to Statins samples (Genotypes/Phenotypes)
EGAD00010000282
|
EGA
Cite
WTCCC2 Pharmacogenomic Response to Statins study
A WTCCC2 project genome-wide study for pharmacogenomic response to statins (PR) in individuals from Scotland.
EGAS00000000121
|
EGA
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets